Related Experiment Video

Updated: May 20, 2026

Effect of Anti-c-fms Antibody on Osteoclast Formation and Proliferation of Osteoclast Precursor In Vitro
07:51

Effect of Anti-c-fms Antibody on Osteoclast Formation and Proliferation of Osteoclast Precursor In Vitro

Published on: March 18, 2019

Interferon-β-induced miR-155 inhibits osteoclast differentiation by targeting SOCS1 and MITF

Jun Zhang1, Hongying Zhao, Jinping Chen

  • 1Department of Orthopedics, Zhejiang Provincial People's Hospital, Hangzhou, PR China.

FEBS Letters
|July 10, 2012
PubMed

Insights

Interferon-beta (IFN-β) inhibits osteoclast differentiation through miR-155, a microRNA that targets SOCS1 and MITF. This discovery offers a new therapeutic strategy for bone diseases.

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Biology

Background:

  • Osteoclast differentiation is regulated by the receptor activator of NF-κB ligand (RANKL)-RANK signaling pathway.
  • Interferon-beta (IFN-β) is induced during osteoclastogenesis and inhibits this process, but its mechanism is not fully understood.

Purpose of the Study:

  • To elucidate the mechanism by which IFN-β suppresses osteoclast differentiation.
  • To identify key molecular players involved in IFN-β-mediated inhibition of osteoclastogenesis.

Main Methods:

  • Investigated the role of microRNAs (miRNAs) in IFN-β's suppressive function.
  • Utilized molecular biology techniques to analyze the targeting of SOCS1 and MITF by miR-155.
  • Assessed the impact of miR-155 on osteoclast differentiation regulators.

Main Results:

  • Identified miR-155 as an IFN-β-induced miRNA that mediates the inhibition of osteoclast differentiation.
  • Demonstrated that miR-155 directly targets SOCS1 and MITF, crucial regulators of osteoclastogenesis.
  • Confirmed that miR-155 plays a key role in suppressing osteoclast differentiation.

Conclusions:

  • miR-155 is a critical mediator of IFN-β's inhibitory effect on osteoclast differentiation.
  • Targeting miR-155 presents a potential therapeutic avenue for osteoclast-mediated bone diseases.

More Related Videos

Differentiation and Characterization of Osteoclasts from Human Induced Pluripotent Stem Cells10:52

Differentiation and Characterization of Osteoclasts from Human Induced Pluripotent Stem Cells

Published on: March 22, 2024

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...